MedPath

tility of DWI-MRI and histopathological evaluation on early response of HCC with molecular targeting therapy

Not Applicable
Recruiting
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000045714
Lead Sponsor
Tokyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Allergy with iodine contrast media 2. eGFR is less than 40ml/min 3. Child-Pugh is B and C 4. Not suitable for the study due to researcher's decision

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath